BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28475402)

  • 1. DNA repair genes PAXIP1 and TP53BP1 expression is associated with breast cancer prognosis.
    De Gregoriis G; Ramos JA; Fernandes PV; Vignal GM; Brianese RC; Carraro DM; Monteiro AN; Struchiner CJ; Suarez-Kurtz G; Vianna-Jorge R; de Carvalho MA
    Cancer Biol Ther; 2017 Jun; 18(6):439-449. PubMed ID: 28475402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAXIP1 Potentiates the Combination of WEE1 Inhibitor AZD1775 and Platinum Agents in Lung Cancer.
    Jhuraney A; Woods NT; Wright G; Rix L; Kinose F; Kroeger JL; Remily-Wood E; Cress WD; Koomen JM; Brantley SG; Gray JE; Haura EB; Rix U; Monteiro AN
    Mol Cancer Ther; 2016 Jul; 15(7):1669-81. PubMed ID: 27196765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive expression of γ-H2AX has prognostic relevance in triple negative breast cancer.
    Nagelkerke A; van Kuijk SJ; Sweep FC; Nagtegaal ID; Hoogerbrugge N; Martens JW; Timmermans MA; van Laarhoven HW; Bussink J; Span PN
    Radiother Oncol; 2011 Oct; 101(1):39-45. PubMed ID: 21840613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of BRCA1 protein in breast cancer and its prognostic significance.
    Rakha EA; El-Sheikh SE; Kandil MA; El-Sayed ME; Green AR; Ellis IO
    Hum Pathol; 2008 Jun; 39(6):857-65. PubMed ID: 18400253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons of p53, KI67 and BRCA1 expressions in patients with different molecular subtypes of breast cancer and their relationships with pathology and prognosis.
    Li Y; Zhang X; Qiu J; Pang T; Huang L; Zeng Q
    J BUON; 2019; 24(6):2361-2368. PubMed ID: 31983107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both high expression of pyruvate kinase M2 and vascular endothelial growth factor-C predicts poorer prognosis in human breast cancer.
    Lin Y; Liu F; Fan Y; Qian X; Lang R; Gu F; Gu J; Fu L
    Int J Clin Exp Pathol; 2015; 8(7):8028-37. PubMed ID: 26339369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of MRE11 in cell proliferation, tumor invasion, and DNA repair in breast cancer.
    Yuan SS; Hou MF; Hsieh YC; Huang CY; Lee YC; Chen YJ; Lo S
    J Natl Cancer Inst; 2012 Oct; 104(19):1485-502. PubMed ID: 22914783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic effects of abnormal DNA damage response protein expression in breast cancer.
    Suh KJ; Ryu HS; Lee KH; Kim H; Min A; Kim TY; Yang Y; Lee HB; Moon HG; Han SW; Oh DY; Han W; Park IA; Noh DY; Im SA
    Breast Cancer Res Treat; 2019 May; 175(1):117-127. PubMed ID: 30671767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal expression of BRCA1 and BRCA1-interactive DNA-repair proteins in breast carcinomas.
    Yoshikawa K; Ogawa T; Baer R; Hemmi H; Honda K; Yamauchi A; Inamoto T; Ko K; Yazumi S; Motoda H; Kodama H; Noguchi S; Gazdar AF; Yamaoka Y; Takahashi R
    Int J Cancer; 2000 Oct; 88(1):28-36. PubMed ID: 10962436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
    Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
    Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expressions of individual PHDs associate with good prognostic factors and increased proliferation in breast cancer patients.
    Peurala E; Koivunen P; Bloigu R; Haapasaari KM; Jukkola-Vuorinen A
    Breast Cancer Res Treat; 2012 May; 133(1):179-88. PubMed ID: 21877141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SND1 expression in breast cancer tumors is associated with poor prognosis.
    Gu X; Xue J; Ai L; Sun L; Zhu X; Wang Y; Liu C
    Ann N Y Acad Sci; 2018 Dec; 1433(1):53-60. PubMed ID: 30216461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA repair pathways to regulate response to chemoradiotherapy in patients with locally advanced head and neck cancer.
    Cirauqui B; Margelí M; Quiroga V; Quer A; Karachaliou N; Chaib I; Ramírez JL; Muñoz A; Pollán C; Planas I; Drozdowsky A; Rosell R
    Tumour Biol; 2016 Oct; 37(10):13435-13443. PubMed ID: 27465548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients.
    Tang J; Deng R; Luo RZ; Shen GP; Cai MY; Du ZM; Jiang S; Yang MT; Fu JH; Zhu XF
    Breast Cancer Res Treat; 2012 Jul; 134(2):549-60. PubMed ID: 22585231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma.
    Zhao P; Lu Y; Jiang X; Li X
    Cancer Sci; 2011 May; 102(5):1107-11. PubMed ID: 21276138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancers with high DSS1 expression that potentially maintains BRCA2 stability have poor prognosis in the relapse-free survival.
    Rezano A; Kuwahara K; Yamamoto-Ibusuki M; Kitabatake M; Moolthiya P; Phimsen S; Suda T; Tone S; Yamamoto Y; Iwase H; Sakaguchi N
    BMC Cancer; 2013 Dec; 13():562. PubMed ID: 24289229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of mismatch repair protein expression in the chemotherapeutic response of sporadic invasive ductal carcinoma of the breast.
    Son BH; Ahn SH; Ko CD; Ka IW; Gong GY; Kim JC
    Breast J; 2004; 10(1):20-6. PubMed ID: 14717755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated nuclear S100P expression is associated with poor survival in early breast cancer patients.
    Maciejczyk A; Łacko A; Ekiert M; Jagoda E; Wysocka T; Matkowski R; Hałoń A; Györffy B; Lage H; Surowiak P
    Histol Histopathol; 2013 Apr; 28(4):513-24. PubMed ID: 23364898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of p16INK4a/p53 in Tunisian patients with breast carcinoma.
    Karray-Chouayekh S; Baccouche S; Khabir A; Sellami-Boudawara T; Daoud J; Frikha M; Jlidi R; Gargouri A; Mokdad-Gargouri R
    Acta Histochem; 2011 Sep; 113(5):508-13. PubMed ID: 20598349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of cyclin D1, β-catenin, and MTA1 in patients with invasive ductal carcinoma of the breast.
    Cheng CW; Liu YF; Yu JC; Wang HW; Ding SL; Hsiung CN; Hsu HM; Shieh JC; Wu PE; Shen CY
    Ann Surg Oncol; 2012 Dec; 19(13):4129-39. PubMed ID: 22864797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.